DMPEN (NSC 682691) (4-Demethylpenclomedine) is a metabolite of the alkylating agent Penclomedine. It exhibits antitumor activity and does not induce Purkinje cell loss or significant cerebellar neurotoxicity in rat cerebellum models. DMPEN is applicable in cancer research, including studies on breast and brain cancer.
Molekulargewicht:
311.38
CAS Nummer:
[176046-79-0]
Formel:
C7H4Cl5NO2
Target-Kategorie:
Drug Metabolite
T212433
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten